H.Con.Res. 35 · 119th Congress · Congress

Exposing Congressional Drug Abuse Act

In committee532 words Introduced Jun 5, 2025 · Latest action Jun 5, 2025

How far it has goneStage 2 of 5
  1. IntroducedJun 5, 2025 Done
  2. CommitteeReferred to House Administration Current stage
  3. House floorNot yet Not reached yet
  4. Senate floorNot yet Not reached yet
  5. Chambers agreeNot yet Not reached yet

What it does

The Congressional Research Service hasn’t published a summary of this bill. Read the full text on Congress.gov.

Who lobbies on it

No lobbying filing on file names H.Con.Res. 35.

Organizations that named H.Con.Res. 35 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. Source: Senate lobbying disclosures (LD-2) from lda.gov; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.

Actions

2 actions · newest first
  1. Jun 5, 2025Referred to the House Committee on House Administration.
  2. Jun 5, 2025Submitted in House

What members said about it

  • Statement · Press release · Jun 6, 2025 · Higgins R-LA

    Higgins Reintroduces Legislation to Drug Test Congress

    Congressman Clay Higgins (R-LA) reintroduced H.Con.Res. 35, the Exposing Congressional Drug Abuse Act, which requires members of the U.S. House of Representatives and U.S. Senate to participate in random drug screenings.

    “Elected officials in Washington, D.C. should be subject to the same kind of random drug screenings that every blue-collar, working-class American endures.”